Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 20 articles:
HTML format



Single Articles


    November 2020
  1. CAMERON ST, Glasier A, McDaid L, Radley A, et al
    Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.
    Lancet. 2020;396:1585-1594.
    PubMed     Abstract available


  2. MARSTON C, Sowemimo A
    Bridge-It trial-a step towards better contraception services.
    Lancet. 2020;396:1536-1537.
    PubMed    


    August 2020
  3. CHU JJ, Devall AJ, Beeson LE, Hardy P, et al
    Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31788.
    PubMed     Abstract available


  4. BARNHART K
    Medical management of miscarriage with mifepristone.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31789.
    PubMed    


    June 2020
  5. ALLEN S, Cortina CS
    An unusual cause of breast hypertrophy: pseudoangiomatous stromal hyperplasia secondary to contraceptive implant.
    Lancet. 2020;395:1937.
    PubMed    


    February 2020
  6. JEWELL BL, Smith JA, Padian NS, van de Wijgert JHHM, et al
    ECHO: context and limitations.
    Lancet. 2020;395:e25-e26.
    PubMed    


  7. GOLLUB EL, Stein Z, van de Wijgert JHHM, Jones H, et al
    ECHO: context and limitations.
    Lancet. 2020;395:e24.
    PubMed    


  8. MARRAZZO J, Balkus JE, Achilles S, Noguchi L, et al
    ECHO: context and limitations.
    Lancet. 2020;395:e23.
    PubMed    


  9. HAPGOOD JP
    ECHO: context and limitations.
    Lancet. 2020;395:e22.
    PubMed    


  10. MIGUEL RDV, Calla NEQ, Aceves KM, Lopez FCD, et al
    ECHO: context and limitations.
    Lancet. 2020;395:e21.
    PubMed    


    July 2019
  11. NOGUCHI LM, Simelela PN
    How should we listen to ECHO?
    Lancet. 2019;394:275-276.
    PubMed    


    June 2019

  12. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Lancet. 2019 Jun 13. pii: S0140-6736(19)31288.
    PubMed     Abstract available


    March 2019
  13. THE LANCET
    Coercive sterilisation of transgender people in Japan.
    Lancet. 2019;393:1262.
    PubMed    


    March 2018
  14. YEE A
    Access to family planning in Senegal.
    Lancet. 2018;391:923-924.
    PubMed    


    February 2018
  15. HABABEH M, Zeidan W, El-Kader MA, Thaher AA, et al
    Contraceptive use by Palestine refugee mothers of young children attending UNRWA clinics: a cross-sectional follow-up study.
    Lancet. 2018;391 Suppl 2:S26.
    PubMed     Abstract available


    December 2017
  16. CAHILL N, Sonneveldt E, Stover J, Weinberger M, et al
    Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33104.
    PubMed     Abstract available


    September 2017
  17. CASASSUS B
    Contraception implant removed from global market.
    Lancet. 2017;390:1576.
    PubMed    


    April 2017
  18. BLANCHARD K, Starrs AM
    Contraception, safe abortion, and the Zika response.
    Lancet. 2017;389:1603.
    PubMed    


    November 2016
  19. THE LANCET
    FP2020: accelerating progress in access to family planning.
    Lancet. 2016;388:2210.
    PubMed    


    October 2016
  20. ZENG Y, Hesketh T
    The effects of China's universal two-child policy.
    Lancet. 2016;388:1930-1938.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: